Oscar Health Q1 net income $679M ($2.07 EPS) vs $275M ($0.92) YoY; revenue $4.65B

Oscar Health, Inc.

2026-Q1 EPS reported $2.07 revenue$4,647,194,000

Revenue $4.65B, up 53% YoY from $3.05B; net income $679M ($2.07 EPS) vs $275M ($0.92 EPS) YoY.
Medical loss ratio improved to 70.5% from 75.4% YoY; SG&A ratio 15.2% from 15.8%.
Membership increased to ~3.17M from ~2.04M, up 55% YoY.
Adjusted EBITDA $727M vs $329M YoY; Company reaffirms full-year 2026 guidance.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Oscar Health, Inc. reported first quarter ended March 31, 2026 results: revenue $4,647,194, net income $678,996, EPS $2.07. Guidance reaffirmed.

Period: first quarter ended March 31, 2026
Revenue: $4,647,194
Net income: $678,996
EPS: $2.07
Guidance: reaffirmed
Result: reported results

Exact text from the filing

results press release dated February 10, 2026. First Quarter 2026 Financial Highlights Three Months Ended March 31, (in thousands, except percentages) 2026 2025 Total revenue $4,647,194 $3,046,263 Medical loss ratio (“MLR”) 70.5% 75.4% Selling, general, and administrative (“SG&A”) expense ratio 15.2% 15.8% Earnings from operations $704,085 $297,123 Net income

View on SEC.gov

13 earnings releases filed in the last 30 days. Browse all earnings releases →

Oscar Health, Inc. filing history →

Source: SEC EDGAR

accession 0001568651-26-000036

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.